Antiphospholipid antibodies and renal outcomes in patients with lupus nephritis

Internal Medicine

Volumn 48, Issue 21, 2009, Pages 1875-1880

  Tsuruta, Yuki ^a   Uchida, Keiko ^a   Itabashi, Mitsuyo ^a   Yumura, Wako ^b   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Antiphospholipid antibody; Lupus nephritis; Prognostic indicator; Renal biopsy; Thrombosis

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTERY THROMBOSIS; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PATIENT ASSESSMENT; PROGNOSIS; RISK FACTOR; SEROPREVALENCE; VEIN THROMBOSIS;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; BIOLOGICAL MARKERS; BIOPSY; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; LUPUS NEPHRITIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 71049155862     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2363     Document Type: Article

References (35)

1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 346: 752-763, 2002.
2. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 42: 1309-1311, 1999. (Pubitemid 30265586)
3. McNeil HP, Hunt JE, Krilis SA. Antiphospholipid antibodies- New insights into their specificity and clinical importance. Scand J Immunol 36: 647-652, 1992.
4. Moroni G, Ventura D, Riva P, et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis 43: 28-36, 2004. (Pubitemid 38049432)
5. Piette JC, Cacoub P, Wechsler B. Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 23: 357-366, 1994.
6. Nochy D, Daugas E, Droz D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10: 507-518, 1999. (Pubitemid 29117632)
7. Daugas E, Nochy D, du Huong LT, et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 13: 42-52, 2002. (Pubitemid 34042010)
8. Frampton G, Hicks J, Cameron JS. Significance of antiphospholipid antibodies in patients with lupus nephritis. Kidney Int 39: 1225-1231, 1991.
9. Farrugia E, Torres VE, Gastineau D, Michet CJ, Holley KE. Lupus anticoagulant in systemic lupus erythematosus: A clinical and renal pathological study. Am J Kidney Dis 20: 463-471, 1992.
10. Gulko PS, Reveille JD, Koopman WJ, Burgard SL, Bartolucci AA, Alarcon GS. Anticardiolipin antibodies in systemic lupus erythematosus: Clinical correlates, HLA associations, and impact on survival. J Rheumatol 20: 1684-1693, 1993.
11. Bhandari S, Harnden P, Brownjohn AM, Turney JH. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM 91: 401-409, 1998. (Pubitemid 28286839)
12. Stratta P, Canavese C, Ferrero S, et al. Catastrophic antiphospholipid syndromes in systemic lupus erythematosus. Ren Fail 21: 49-61, 1999. (Pubitemid 29085224)
13. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997.
14. Imai E, Horio M, Nitta K, et al. Modification of the modification of diet in renal disease (MDRD) study equation for Japan. Am J Kidney Dis 50: 927-937, 2007. (Pubitemid 350130278)
15. Koike M, Takei T, Uchida K, et al. Clinical assessment of lowdose steroid therapy for patients with IgA nephropathy: a prospective study in a single center. Clin Exp Nephrol 12: 250-255, 2008.
16. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15: 241-250, 2004. (Pubitemid 38140764)
17. Harris EN, Gharavi AE, Patel BM, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 68: 215-222, 1987.
18. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for define antiphospholipid syndrome (APS). J Thromb Haemost 4: 295-306, 2006.
19. Petri M. Thrombosis and systemic lupus erythematosus: The Hopkins Lupus Cohort perspective. Scand J Rheumatol 25: 191-193, 1996. (Pubitemid 26273848)
20. Wahl DG, Guillemin F, Maistre E, et al. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus: a meta-analysis. Lupus 6: 467-473, 1997. (Pubitemid 27395386)
21. Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM. Risk factors for thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum 61: 29-36, 2009.
22. Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD. Across-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology 41: 924-929, 2002. (Pubitemid 34905870)
23. Font J, Ramos-Casals M, Cervera R, et al. Cardiovascular risk factors and the long-term outcome of lupus nephritis. QJM 94: 19-26, 2001. (Pubitemid 32098130)
24. Atsumi T, Khamashta MA, Haworth RS, et al. Arterial disease and thrombosis in the antiphospholipid syndrome: A pathogenic role for endothelin 1. Arthritis Rheum 41: 800-807, 1998. (Pubitemid 28225779)
25. Korkmaz C, Kabukcuoglu S, Isilksoy S, Yalcin AU. Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy. Lupus 12: 760-765, 2003. (Pubitemid 37295811)
26. Perdiguero M, Boronat M, Marco P, Rivera F. The role of antiphospholipid antibodies in lupus nephropathy. Nephron 71: 35-39, 1995.
27. Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller AN, Hess EV. Glomerular thrombosis in systemic lupus erythematosus: Prevalence and significance. Medicine 60: 71-86, 1981. (Pubitemid 11047409)
28. D'Agati V, Kunis C, Williams G, Appel GB. Anticardiolipin antibody and renal disease: A report of three cases. J Am Soc Nephrol 1: 777-784, 1990.
29. Levy Y, Gearge J, Ziporen L, et al. Massive proteinuria as a main manifestation of primary antiphospholipid syndrome. Pathobiology 66: 49-52, 1998. (Pubitemid 28140604)
30. Moroni G, Ventura D, Riva P, et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis 43: 28-36, 2004. (Pubitemid 38049432)
31. Esdaile JM, Federgreen W, Quintal H, et al. Predictors of one year outcome in lupus nephritis: The importance of renal biopsy. Q J Med 81: 907-918, 1991.
32. Esdaile JM, Federgreen W, Quintal H, et al. Predictors of one year outcome in lupus nephritis: The importance of renal biopsy. Q J Med 81: 907-918, 1991.
33. Austin HA III, Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe lupus nephritis. Contributions of clinical and histologic data. Kidney Int 45: 544-550, 1994.
34. Austin HA III, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: Importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 10: 1620-1628, 1995.
35. Moroni G, Quaglini S, Maccario M, Banfi G, Ponticelli C. "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 50: 2047-2053, 1996.